Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Formosa Laboratories, Inc. (4746) Financial Statements

Formosa Laboratories, Inc. Financial Overview

Formosa Laboratories, Inc.'s market cap is currently NT$5.43B. The company's EPS TTM is NT$3.97; its P/E ratio is 11.42; and it has a dividend yield of 6.61%. Formosa Laboratories, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 4.85BNT$ 4.73BNT$ 4.36BNT$ 3.77BNT$ 3.14B
Gross ProfitNT$ 2.03BNT$ 2.05BNT$ 1.92BNT$ 1.39BNT$ 971.44M
Operating IncomeNT$ 803.18MNT$ 750.04MNT$ 674.98MNT$ 380.85MNT$ 1.10B
EBITDANT$ 1.35BNT$ 746.86MNT$ 1.16BNT$ 823.41MNT$ 1.59B
Net IncomeNT$ 441.11MNT$ 157.27MNT$ 126.24MNT$ 216.81MNT$ 1.25B
Balance Sheet
Cash & Short-Term InvestmentsNT$ 2.49BNT$ 2.70BNT$ 2.51BNT$ 1.63BNT$ 1.09B
Total AssetsNT$ 13.83BNT$ 13.90BNT$ 13.64BNT$ 12.75BNT$ 12.02B
Total DebtNT$ 3.61BNT$ 3.90BNT$ 4.06BNT$ 3.80BNT$ 3.42B
Net DebtNT$ 2.47BNT$ 2.54BNT$ 2.54BNT$ 2.52BNT$ 2.69B
Total LiabilitiesNT$ 5.16BNT$ 5.25BNT$ 5.43BNT$ 4.95BNT$ 4.41B
Stockholders' EquityNT$ 7.76BNT$ 7.68BNT$ 7.57BNT$ 7.52BNT$ 7.40B
Cash Flow
Free Cash FlowNT$ 472.12MNT$ 138.46MNT$ 286.09MNT$ 203.10MNT$ -202.66M
Operating Cash FlowNT$ 1.32BNT$ 726.33MNT$ 826.60MNT$ 643.09MNT$ 311.16M
Investing Cash FlowNT$ -845.30MNT$ -1.03BNT$ -1.26BNT$ -540.72MNT$ -589.49M
Financing Cash FlowNT$ -677.96MNT$ 132.09MNT$ 117.46MNT$ 447.94MNT$ 439.02M

Currency in TWD

Formosa Laboratories, Inc. Earnings and Revenue History

-3B03B6B-25 %0 %25 %50 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Formosa Laboratories, Inc. Liabilities to Assets

05B10B15B32 %40 %48 %56 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Formosa Laboratories, Inc. Cash Flow

-2B-1.5B-1B-500M0500M1B1.5B2B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Formosa Laboratories, Inc. Forecast EPS vs Actual EPS

-2-101234Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >